Shell Companies · Financial Services
CFO
2025-06-03–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Oaktree Acquisition Corp. III Life Sciences publishes a filing, an earnings call transcript or a press release.
Get OACC alertsThomas Sweeney is recorded as CFO at Oaktree Acquisition Corp. III Life Sciences (OACC) since June 3, 2025. Oaktree Acquisition Corp. III Life Sciences reported in an 8-K filed October 29, 2025 that Thomas Sweeney resigned as Chief Financial Officer, effective October 29, 2025. The same filing states: “Mr. Sweeney’s resignation was not the result of any disagreements with the Board or management of the Company and he is resigning to pursue other professional opportunities.” Oaktree Acquisition Corp. III Life Sciences reported in an 8-K filed June 6, 2025 that Thomas Sweeney was appointed Chief Financial Officer (principal accounting and principal financial officer), effective June 3, 2025. Oaktree Acquisition Corp. III Life Sciences is classified in the Shell Companies industry within the Financial Services sector. Other leadership on record at Oaktree Acquisition Corp. III Life Sciences includes Aman Kumar (Chairman), George A. Martinez (CFO), David A. Berry (Board Member) and 2 others.
“On October 29, 2025, Thomas Sweeney notified the board of directors (the “Board”) of Oaktree Acquisition Corp. III Life Sciences (the “Company”) of his resignation as Chief Financial Officer of the Company.”
“Mr. Sweeney’s resignation was not the result of any disagreements with the Board or management of the Company and he is resigning to pursue other professional opportunities.”
“On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.”
2025-06-03–present
2025-06-03–2025-10-29
Shell Companies · Financial Services
CFO
2025-06-03–present
“Mr. Sweeney’s resignation was not the result of any disagreements with the Board or management of the Company and he is resigning to pursue other professional opportunities.”
Oaktree Acquisition Corp. III Life Sciences (OACC)